Arsenal

Akero vs. Madrigal: The Battle for MASH Treatment Supremacy

Arsenal April 22, 2024

Ensysce’s Noble Conference Presentation Now Available on IR Website

Arsenal April 19, 2024

La Jolla Institute, RevolKa Collaborate on Next-Gen Vaccine Antigens

Arsenal April 19, 2024

Addex Therapeutics: 2023 Financial Results and Corporate Update

Arsenal April 18, 2024

TaiGen’s TG-1000 Influenza Antiviral Completes Successful Phase III Study

Arsenal April 18, 2024

Genentech’s Subcutaneous Ocrevus Shows Promising Results in MS Patients

Arsenal April 17, 2024

Spago Nanomedical Appoints Birgitta Rembratt Svensson as Head of CMC & Supply

Arsenal April 16, 2024

Innovent Appoints Renowned Oncology Leader Dr. Nageatte Ibrahim as CMO

Arsenal April 16, 2024

Nxera Pharma Inks Exclusive PIVLAZ™ Distribution Deal with Handok in South Korea

Arsenal April 15, 2024

4 Novel Weight Loss Drugs Poised to Disrupt the Obesity Treatment Market

Arsenal April 15, 2024

Nurix Therapeutics: $175M Public Offering Priced at $15/Share

Arsenal April 12, 2024

Rakuten Medical: COX-2 Inhibition Reduces Photoimmunotherapy-Induced Edema in Mice (AACR 2024)

Arsenal April 12, 2024

Nuevocor Appoints John Lee, MD, PhD as Chief Medical Officer

Arsenal April 11, 2024

Mirum Grants Stock Options and RSUs to New Employees

Arsenal April 11, 2024

Pharma Loses Millions Due to Poor Customer Data Management

Arsenal April 10, 2024

Novartis Streamlines Global Development Team to Drive Strategic Focus

Arsenal April 9, 2024

Diakonos’ DC Vaccine Improves Survival in Phase 1 Glioblastoma Trial

Arsenal April 9, 2024

Abbisko Enrolls Final Patient in Pimicotinib’s Phase III TGCT Trial

Arsenal April 9, 2024

5 Cancer Drugs Ace Phase 3 Trials, Offering New Hope

Arsenal April 8, 2024

Top 10 Oncology Breakthroughs: Game-Changing Phase III Trials in Q1 2024

Arsenal April 8, 2024

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Iovance Biotherapeutics Stock Plummets 44%: What Investors Need to Know About 2025 Projections

Insilico Medicine’s Third Attempt at an IPO: Aiming Big in Hong Kong’s Booming Biotech Market

Biotech Sector Faces Major Workforce Cuts: Layoffs Surge as Firms Navigate Market Turbulence

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA

Arsenal

Akero vs. Madrigal: The Battle for MASH Treatment Supremacy

Ensysce’s Noble Conference Presentation Now Available on IR Website

La Jolla Institute, RevolKa Collaborate on Next-Gen Vaccine Antigens

Addex Therapeutics: 2023 Financial Results and Corporate Update

TaiGen’s TG-1000 Influenza Antiviral Completes Successful Phase III Study

Genentech’s Subcutaneous Ocrevus Shows Promising Results in MS Patients

Spago Nanomedical Appoints Birgitta Rembratt Svensson as Head of CMC & Supply

Innovent Appoints Renowned Oncology Leader Dr. Nageatte Ibrahim as CMO

Nxera Pharma Inks Exclusive PIVLAZ™ Distribution Deal with Handok in South Korea

4 Novel Weight Loss Drugs Poised to Disrupt the Obesity Treatment Market

Nurix Therapeutics: $175M Public Offering Priced at $15/Share

Rakuten Medical: COX-2 Inhibition Reduces Photoimmunotherapy-Induced Edema in Mice (AACR 2024)

Nuevocor Appoints John Lee, MD, PhD as Chief Medical Officer

Mirum Grants Stock Options and RSUs to New Employees

Pharma Loses Millions Due to Poor Customer Data Management

Novartis Streamlines Global Development Team to Drive Strategic Focus

Diakonos’ DC Vaccine Improves Survival in Phase 1 Glioblastoma Trial

Abbisko Enrolls Final Patient in Pimicotinib’s Phase III TGCT Trial

5 Cancer Drugs Ace Phase 3 Trials, Offering New Hope

Top 10 Oncology Breakthroughs: Game-Changing Phase III Trials in Q1 2024

Stay up to date on the latest news

Access the Ideas that Accelerate Innovation

Trending News

Iovance Biotherapeutics Stock Plummets 44%: What Investors Need to Know About 2025 Projections

Insilico Medicine’s Third Attempt at an IPO: Aiming Big in Hong Kong’s Booming Biotech Market

Biotech Sector Faces Major Workforce Cuts: Layoffs Surge as Firms Navigate Market Turbulence

Popular Categories

Information

Contact Us